April 5, 2023
Shionogi said on April 4 that the US FDA has granted Fast Track designation for its oral antiviral agent Xocova (ensitrelvir) for the treatment of COVID-19. Xocova received emergency approval in Japan last November. It remains an investigational drug outside Japan.read more